Indian pharma company Lupin will make an expensive deal of buying less known US company Gavis for $880 million for its portfolio of specialised products and is hoping to safeguard sales in the all important US market which contributes nearly half of Lupin’s revenue.

Other Important Headlines

  • Flipkart and Snapdeal seeks to raise billion-$ this festive season.
  • Wipro encourages employees by giving promotion and hike to high performers.
  • Govt. to hire five consultancies to pull ‘Digital India’ cart.